A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...

"Now that we know how Aplp1 and Lag3 interact, we have a new way of understanding how alpha-synuclein contributes to the ...

Stop the Spread. Injecting saline into mouse kidneys did not affect the left or right substantia nigra (top). Injecting fibrils of α-synuclein ablated about half of the dopaminergic neurons (middle ...

Over time, the disease can also affect memory and lead to dementia. A similar condition called Lewy Body Dementia (LBD), ...

"We will continue our close collaboration with the Parkinson's community as we further evaluate the data to determine next steps." Alpha-synuclein is a protein that tends to get misfolded and ...

The assay for a particular abnormal form of the protein alpha-synuclein – known as αSyn-SAA – could also be used to diagnose people with Parkinson’s more quickly, help identify the best ...

Researchers develop NANO system to treat Parkinsons symptoms without surgery Innovative approach using nanoparticles offers ...

Parkinson’s is characterized by accumulation and aggregation of α-synuclein in certain areas of the brain such as the substantia nigra, and neuroinflammation. Neuroinflammation can be measured ...

The B vitamin mitigates manganese neurotoxicity, which produces symptoms that resemble Parkinson's disease. The vitamin improves dopamine production in the brain and offers potential therapeutic ...